nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—MMP9—cornea—ocular cancer	0.113	0.487	CbGeAlD
Glucosamine—NFKB2—lymphoid tissue—ocular cancer	0.0226	0.0971	CbGeAlD
Glucosamine—IFNG—eye—ocular cancer	0.0218	0.0935	CbGeAlD
Glucosamine—IFNG—epithelium—ocular cancer	0.0199	0.0855	CbGeAlD
Glucosamine—IFNG—lymphoid tissue—ocular cancer	0.0153	0.0658	CbGeAlD
Glucosamine—MMP9—eye—ocular cancer	0.014	0.06	CbGeAlD
Glucosamine—MMP9—epithelium—ocular cancer	0.0128	0.0549	CbGeAlD
Glucosamine—MMP9—lymphoid tissue—ocular cancer	0.00985	0.0423	CbGeAlD
Glucosamine—CYP2E1—lymphoid tissue—ocular cancer	0.00324	0.0139	CbGeAlD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00314	0.00409	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—CCND1—ocular cancer	0.00314	0.00409	CbGpPWpGaD
Glucosamine—NFKB2—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—EP300—ocular cancer	0.00313	0.00408	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—CDK4—ocular cancer	0.00312	0.00407	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—MDM2—ocular cancer	0.0031	0.00404	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—CCND1—ocular cancer	0.00306	0.00399	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—MDM2—ocular cancer	0.00305	0.00397	CbGpPWpGaD
Glucosamine—MMP9—Angiogenesis—AKT1—ocular cancer	0.00304	0.00396	CbGpPWpGaD
Glucosamine—MMP9—Syndecan-1-mediated signaling events—TGFB1—ocular cancer	0.00303	0.00395	CbGpPWpGaD
Glucosamine—IFNG—IL2-mediated signaling events—MYC—ocular cancer	0.00302	0.00394	CbGpPWpGaD
Glucosamine—IFNG—TGF-beta Receptor Signaling—TGFB1—ocular cancer	0.00302	0.00393	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TFDP1—ocular cancer	0.00299	0.0039	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—RB1—ocular cancer	0.00298	0.00389	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—E2F1—ocular cancer	0.0029	0.00379	CbGpPWpGaD
Glucosamine—NFKB2—TSLP Signaling Pathway—AKT1—ocular cancer	0.00289	0.00377	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—ocular cancer	0.00288	0.00376	CbGpPWpGaD
Glucosamine—TNF—FAS pathway and Stress induction of HSP regulation—RB1—ocular cancer	0.00288	0.00375	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—EP300—ocular cancer	0.00282	0.00368	CbGpPWpGaD
Glucosamine—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—ocular cancer	0.0028	0.00364	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—CDKN1B—ocular cancer	0.00278	0.00363	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—RB1—ocular cancer	0.00272	0.00354	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00268	0.00349	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—CCND1—ocular cancer	0.00265	0.00346	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—CDKN1A—ocular cancer	0.00261	0.0034	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—TP53—ocular cancer	0.00261	0.0034	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—RB1—ocular cancer	0.00259	0.00337	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—CDKN1A—ocular cancer	0.00257	0.00335	CbGpPWpGaD
Glucosamine—NFKB2—RANKL/RANK Signaling Pathway—AKT1—ocular cancer	0.00255	0.00332	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—MDM2—ocular cancer	0.00254	0.00331	CbGpPWpGaD
Glucosamine—IFNG—IFN-gamma pathway—AKT1—ocular cancer	0.00252	0.00328	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—MYC—ocular cancer	0.00251	0.00328	CbGpPWpGaD
Glucosamine—TNF—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ocular cancer	0.00251	0.00327	CbGpPWpGaD
Glucosamine—TNF—IL27-mediated signaling events—TGFB1—ocular cancer	0.00251	0.00327	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—TGFB1—ocular cancer	0.00251	0.00327	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CDK2—ocular cancer	0.0025	0.00327	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—EP300—ocular cancer	0.00248	0.00324	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—MYC—ocular cancer	0.00246	0.0032	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—TGFB1—ocular cancer	0.00245	0.0032	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—TGFB1—ocular cancer	0.00244	0.00318	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—CDKN1B—ocular cancer	0.00243	0.00317	CbGpPWpGaD
Glucosamine—IFNG—IL2-mediated signaling events—HRAS—ocular cancer	0.00238	0.0031	CbGpPWpGaD
Glucosamine—IFNG—TGF-beta Receptor Signaling—HRAS—ocular cancer	0.00238	0.0031	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CDK4—ocular cancer	0.00237	0.00309	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—CCND1—ocular cancer	0.00232	0.00303	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—CDKN1B—ocular cancer	0.00232	0.00303	CbGpPWpGaD
Glucosamine—NFKB2—Neural Crest Differentiation—MYC—ocular cancer	0.00226	0.00295	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—HRAS—ocular cancer	0.00224	0.00292	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—HRAS—ocular cancer	0.00224	0.00292	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—TGFB1—ocular cancer	0.00223	0.0029	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—CDKN1A—ocular cancer	0.00214	0.00279	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—EP300—ocular cancer	0.00214	0.00279	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—MYC—ocular cancer	0.00213	0.00277	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—TGFB1—ocular cancer	0.00212	0.00277	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—TP53—ocular cancer	0.00212	0.00276	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—CDKN1B—ocular cancer	0.00211	0.00276	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ocular cancer	0.00209	0.00272	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00208	0.00272	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.00208	0.00272	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—RB1—ocular cancer	0.00206	0.00268	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—CDK4—ocular cancer	0.00204	0.00266	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—HRAS—ocular cancer	0.00202	0.00264	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—TP53—ocular cancer	0.00202	0.00263	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—CCND1—ocular cancer	0.00202	0.00263	CbGpPWpGaD
Glucosamine—MMP9—Endochondral Ossification—TGFB1—ocular cancer	0.002	0.0026	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—AKT1—ocular cancer	0.00198	0.00258	CbGpPWpGaD
Glucosamine—MMP9—TWEAK Signaling Pathway—AKT1—ocular cancer	0.00194	0.00253	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—EP300—ocular cancer	0.00194	0.00253	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.00192	0.00251	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—ocular cancer	0.00192	0.0025	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—HRAS—ocular cancer	0.00191	0.0025	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—MYC—ocular cancer	0.00186	0.00243	CbGpPWpGaD
Glucosamine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1B—ocular cancer	0.00186	0.00243	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TGFB1—ocular cancer	0.00186	0.00242	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00183	0.00239	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00183	0.00239	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00183	0.00239	CbGpPWpGaD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—ocular cancer	0.0018	0.00235	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—E2F1—ocular cancer	0.00178	0.00232	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.00178	0.00232	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TGFB1—ocular cancer	0.00177	0.00231	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—CCND3—ocular cancer	0.00175	0.00228	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—TP53—ocular cancer	0.00175	0.00228	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—AKT1—ocular cancer	0.00174	0.00227	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.00173	0.00225	CbGpPWpGaD
Glucosamine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1A—ocular cancer	0.00172	0.00224	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—MYC—ocular cancer	0.00169	0.0022	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—AKT1—ocular cancer	0.00169	0.0022	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—HRAS—ocular cancer	0.00168	0.00219	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.00167	0.00218	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—HRAS—ocular cancer	0.00167	0.00218	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—E2F1—ocular cancer	0.00165	0.00215	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—MYC—ocular cancer	0.00162	0.00211	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TGFB1—ocular cancer	0.00161	0.0021	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—EP300—ocular cancer	0.00161	0.0021	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CDKN1B—ocular cancer	0.0016	0.00209	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.0016	0.00208	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.00159	0.00207	CbGpPWpGaD
Glucosamine—MMP9—FGF signaling pathway—AKT1—ocular cancer	0.00159	0.00207	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—HRAS—ocular cancer	0.00157	0.00205	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.00156	0.00203	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—MYC—ocular cancer	0.00154	0.00201	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CDK2—ocular cancer	0.00153	0.002	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TP53—ocular cancer	0.00153	0.00199	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CCND1—ocular cancer	0.00153	0.00199	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—ocular cancer	0.00153	0.00199	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—MDM2—ocular cancer	0.00152	0.00198	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.0015	0.00196	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—AKT1—ocular cancer	0.00148	0.00192	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TP53—ocular cancer	0.00146	0.0019	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CDK4—ocular cancer	0.00145	0.00189	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—E2F1—ocular cancer	0.00143	0.00186	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—MDM2—ocular cancer	0.00141	0.00184	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—TGFB1—ocular cancer	0.0014	0.00182	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—HRAS—ocular cancer	0.0014	0.00182	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—CDKN1B—ocular cancer	0.00139	0.00181	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—TP53—ocular cancer	0.00139	0.00181	CbGpPWpGaD
Glucosamine—MMP9—Endochondral Ossification—AKT1—ocular cancer	0.00139	0.00181	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—AKT1—ocular cancer	0.00139	0.00181	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—TGFB1—ocular cancer	0.00138	0.0018	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—AKT1—ocular cancer	0.00135	0.00176	CbGpPWpGaD
Glucosamine—CYP2E1—Tryptophan metabolism—MDM2—ocular cancer	0.00133	0.00173	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TP53—ocular cancer	0.00133	0.00173	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00132	0.00172	CbGpPWpGaD
Glucosamine—TNF—Signaling events mediated by HDAC Class I—EP300—ocular cancer	0.00131	0.00171	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—CDKN1A—ocular cancer	0.00128	0.00167	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—RB1—ocular cancer	0.00126	0.00164	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00125	0.00163	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—MYC—ocular cancer	0.00123	0.0016	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TGFB1—ocular cancer	0.00122	0.00159	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.00121	0.00158	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—EP300—ocular cancer	0.00121	0.00158	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00121	0.00158	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—AKT1—ocular cancer	0.00119	0.00155	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—RB1—ocular cancer	0.00117	0.00152	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—HRAS—ocular cancer	0.00116	0.00151	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—AKT1—ocular cancer	0.00112	0.00145	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—HRAS—ocular cancer	0.0011	0.00144	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CCND3—ocular cancer	0.00107	0.0014	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—AKT1—ocular cancer	0.00107	0.00139	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—ocular cancer	0.00105	0.00137	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00104	0.00136	CbGpPWpGaD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—AKT1—ocular cancer	0.00103	0.00135	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—TGFB1—ocular cancer	0.00103	0.00135	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TP53—ocular cancer	0.00101	0.00131	CbGpPWpGaD
Glucosamine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—ocular cancer	0.000988	0.00129	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000986	0.00129	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—MYC—ocular cancer	0.000985	0.00128	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—ocular cancer	0.000983	0.00128	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—TP53—ocular cancer	0.000981	0.00128	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CDKN1B—ocular cancer	0.000981	0.00128	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—AKT1—ocular cancer	0.000959	0.00125	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—ocular cancer	0.000939	0.00122	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SAG—ocular cancer	0.000938	0.00122	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CCND1—ocular cancer	0.000936	0.00122	CbGpPWpGaD
Glucosamine—TNF—Caspase Cascade in Apoptosis—AKT1—ocular cancer	0.000932	0.00121	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—ocular cancer	0.00085	0.00111	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—CDKN1A—ocular cancer	0.000838	0.00109	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—HRAS—ocular cancer	0.000835	0.00109	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—E2F5—ocular cancer	0.00083	0.00108	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—E2F4—ocular cancer	0.000813	0.00106	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—ocular cancer	0.000809	0.00105	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—MDM2—ocular cancer	0.000803	0.00105	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RBL1—ocular cancer	0.000797	0.00104	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—HRAS—ocular cancer	0.000786	0.00102	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—CDK4—ocular cancer	0.000753	0.000982	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MYC—ocular cancer	0.000751	0.000979	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TGFB1—ocular cancer	0.000749	0.000976	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—AKT1—ocular cancer	0.000737	0.000961	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CDKN1B—ocular cancer	0.000733	0.000956	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000731	0.000953	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—HRAS—ocular cancer	0.00072	0.000938	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—TGFB1—ocular cancer	0.000693	0.000904	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—E2F3—ocular cancer	0.000691	0.000901	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000689	0.000898	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—ocular cancer	0.000683	0.000891	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—AKT1—ocular cancer	0.000683	0.000891	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CDKN1A—ocular cancer	0.000677	0.000882	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000667	0.00087	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—EP300—ocular cancer	0.000644	0.000839	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TFDP1—ocular cancer	0.000643	0.000838	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—TGFB1—ocular cancer	0.000642	0.000837	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000637	0.00083	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HRAS—ocular cancer	0.000637	0.00083	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—AKT1—ocular cancer	0.000635	0.000828	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—ocular cancer	0.000617	0.000804	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000616	0.000803	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PSPH—ocular cancer	0.000604	0.000787	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000586	0.000764	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.000585	0.000763	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MYC—ocular cancer	0.000566	0.000738	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TGFB1—ocular cancer	0.000565	0.000736	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000511	0.000666	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MAML2—ocular cancer	0.000511	0.000666	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00051	0.000664	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—ocular cancer	0.000496	0.000646	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—MDM2—ocular cancer	0.000468	0.00061	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PSPH—ocular cancer	0.000466	0.000607	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—ocular cancer	0.000465	0.000606	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CDK4—ocular cancer	0.000461	0.000601	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000457	0.000595	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—EP300—ocular cancer	0.000448	0.000583	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GNA11—ocular cancer	0.000446	0.000581	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—HRAS—ocular cancer	0.000441	0.000574	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—HRAS—ocular cancer	0.000429	0.00056	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CDKN1B—ocular cancer	0.000427	0.000557	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000419	0.000547	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—AKT1—ocular cancer	0.000419	0.000546	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GNAQ—ocular cancer	0.000414	0.00054	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CDKN1A—ocular cancer	0.000394	0.000514	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—AKT1—ocular cancer	0.000392	0.000512	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TGFB1—ocular cancer	0.000389	0.000507	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—AKT1—ocular cancer	0.000389	0.000507	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MDM2—ocular cancer	0.000379	0.000494	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—EP300—ocular cancer	0.000375	0.000489	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HDAC1—ocular cancer	0.000373	0.000487	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000354	0.000462	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CDKN1B—ocular cancer	0.000346	0.000451	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CDKN2B—ocular cancer	0.000335	0.000436	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CDKN1A—ocular cancer	0.000319	0.000416	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—E2F1—ocular cancer	0.000307	0.0004	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—HRAS—ocular cancer	0.000306	0.000399	CbGpPWpGaD
Glucosamine—IFNG—Immune System—EP300—ocular cancer	0.000304	0.000396	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—EP300—ocular cancer	0.000274	0.000357	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—AKT1—ocular cancer	0.00027	0.000353	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HRAS—ocular cancer	0.000257	0.000335	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—TGFB1—ocular cancer	0.000238	0.000311	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—AKT1—ocular cancer	0.000227	0.000295	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HRAS—ocular cancer	0.000208	0.000271	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GNA11—ocular cancer	0.00019	0.000248	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—HRAS—ocular cancer	0.000188	0.000244	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MDM2—ocular cancer	0.000186	0.000242	CbGpPWpGaD
Glucosamine—IFNG—Immune System—AKT1—ocular cancer	0.000184	0.000239	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GNAQ—ocular cancer	0.000177	0.00023	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CDKN1B—ocular cancer	0.00017	0.000221	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—AKT1—ocular cancer	0.000166	0.000216	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCND1—ocular cancer	0.000162	0.000211	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CDKN1A—ocular cancer	0.000156	0.000204	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EP300—ocular cancer	0.000149	0.000194	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GNA11—ocular cancer	0.000147	0.000191	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GNAQ—ocular cancer	0.000136	0.000178	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MYC—ocular cancer	0.00013	0.000169	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TGFB1—ocular cancer	0.000129	0.000169	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00011	0.000143	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—ocular cancer	0.000107	0.000139	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HRAS—ocular cancer	0.000102	0.000133	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AKT1—ocular cancer	9e-05	0.000117	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—EP300—ocular cancer	6.35e-05	8.27e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—EP300—ocular cancer	4.9e-05	6.38e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—AKT1—ocular cancer	3.83e-05	5e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—AKT1—ocular cancer	2.96e-05	3.86e-05	CbGpPWpGaD
